Welcome to hiintermediates.com,intermediates trading platform
Home > products > Benzenesulfonamide,4-amino-N-[(butylamino)carbonyl]-

Benzenesulfonamide,4-amino-N-[(butylamino)carbonyl]- cas no:339-43-5

Synonyms: Sulfanilamide,N1-(butylcarbamoyl)- (6CI);Urea,1-butyl-3-sulfanilyl- (7CI,8CI);1-Butyl-3-sulfanilylurea; Alentin;Aminophenurobutane;BZ 55;Bucarban;Bucrol;Bukarban;Burcol;Butisulfina;Carbutamid;Carbutamide;Diaboral;Emedan;Glucidoral; Glucofren;Glybutamide;Inbuton;Invenol;N-(4-Aminobenzenesulfonyl)-N'-butylurea;N-Butyl-N'-sulfanilylurea;N-Sulfanilyl-N'-butylurea;NSC 242409;NSC 246862;Nadisan;Nadizan;Norboral;N'-(4-Aminobenzenesulfonyl)-N-butylurea;N'-(4-Aminophenylsulfonyl)-N-butylurea;N'-(4-Aminophenylsulfonyl)-N-n-butylurea;N'-(Butylcarbamoyl)sulfanilamide;Oranil;Oranyl;Orasulin;U 6987

Identification
NameBenzenesulfonamide,4-amino-N-[(butylamino)carbonyl]-
CAS339-43-5
SynonymsSulfanilamide,N1-(butylcarbamoyl)- (6CI);Urea,1-butyl-3-sulfanilyl- (7CI,8CI);1-Butyl-3-sulfanilylurea; Alentin;Aminophenurobutane;BZ 55;Bucarban;Bucrol;Bukarban;Burcol;Butisulfina;Carbutamid;Carbutamide;Diaboral;Emedan;Glucidoral; Glucofren;Glybutamide;Inbuton;Invenol;N-(4-Aminobenzenesulfonyl)-N'-butylurea;N-Butyl-N'-sulfanilylurea;N-Sulfanilyl-N'-butylurea;NSC 242409;NSC 246862;Nadisan;Nadizan;Norboral;N'-(4-Aminobenzenesulfonyl)-N-butylurea;N'-(4-Aminophenylsulfonyl)-N-butylurea;N'-(4-Aminophenylsulfonyl)-N-n-butylurea;N'-(Butylcarbamoyl)sulfanilamide;Oranil;Oranyl;Orasulin;U 6987
EINECS(EC#)206-424-4
Molecular FormulaC11H17 N3 O3 S
Molecular Weight271.37
Chemical Properties
refractive index1.564
Safety Data

Safety

A poison by intraperitoneal route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits very toxic fumes of NOx and SOx.


Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 250mg/kg (250mg/kg)   National Technical Information Service. Vol. AD691-490,
mouse LD50 intravenous 1920mg/kg (1920mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Diabetes. Vol. 6, Pg. 2, 1957.
mouse LD50 oral 2800mg/kg (2800mg/kg)   Farmakologiya i Toksikologiya Vol. 25, Pg. 93, 1962.
mouse LD50 subcutaneous 2640mg/kg (2640mg/kg)   Diabetes. Vol. 6, Pg. 2, 1957.
rat LD50 intravenous 980mg/kg (980mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Diabetes. Vol. 6, Pg. 2, 1957.
rat LD50 oral 4400mg/kg (4400mg/kg)   French Demande Patent Document. Vol. #2390165,

supplier list

Boc Sciences
Tel:1-631-5046093
Address: 45-16 Ramsey Road, Shirley, NY 11967, USA

Home   |   About Us   |   Service   |   Links   |   Add to  Favorite

Copyright©2011 HiIntermediates ICP: B2-20090288 浙ICP备09045134号-49
Tel: +86-0571-89739792